Literature DB >> 28348087

Site Principal Investigators in Multicenter Clinical Trials: Appropriately Recognizing Key Contributors.

Robert J Mentz1, Eric D Peterson2.   

Abstract

Entities:  

Keywords:  clinical science

Mesh：

Year:  2017        PMID： 28348087      PMCID： PMC5375038          DOI： 10.1161/CIRCULATIONAHA.116.026650

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results.

Authors:  David J Whellan; William E Kraus; Dalane W Kitzman; Bridget Rooney; Steven J Keteyian; Ileana L Piña; Stephen J Ellis; Jalal K Ghali; Kerry L Lee; Lawton S Cooper; Christopher M O'Connor
Journal:  Am Heart J       Date:  2015-01-10       Impact factor: 4.749

2.  Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.

Authors:  Ann Scheck McAlearney; Paula H Song; Kristin L Reiter
Journal:  Contemp Clin Trials       Date:  2012-08-19       Impact factor: 2.226

3.  Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review.

Authors:  Ben Fletcher; Adrian Gheorghe; David Moore; Sue Wilson; Sarah Damery
Journal:  BMJ Open       Date:  2012-01-06       Impact factor: 2.692
  3 in total
  2 in total

1.  The contributor roles for randomized controlled trials and the proposal for a novel CRediT-RCT.

Authors:  Zhongheng Zhang; Stephen D Wang; Grace S Li; Guilan Kong; Hongqiu Gu; Fernando Alfonso
Journal:  Ann Transl Med       Date:  2019-12

2.  Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives.

Authors:  Aniek Dane; Soedaba Ashraf; James Timmis; Monique Bos; Carin Uyl-de Groot; P Hugo M van der Kuy
Journal:  BMJ Open       Date:  2022-02-17       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.